27456062|t|Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
27456062|a|Spinal Muscular Atrophy is due to the loss of SMN1 gene function. The duplicate gene SMN2 produces some, but not enough, SMN protein because most transcripts lack exon 7. Thus, promoting the inclusion of this exon is a therapeutic option. We show that a somatic gene therapy using the gene for a modified U7 RNA which stimulates this splicing has a profound and persistent therapeutic effect on the phenotype of a severe Spinal Muscular Atrophy mouse model. To this end, the U7 gene and vector and the production of pure, highly concentrated self-complementary (sc) adenovirus - associated virus 9 vector particles were optimized. Introduction of the functional vector into motoneurons of newborn Spinal Muscular Atrophy mice by intracerebroventricular injection led to a highly significant, dose-dependent increase in life span and improvement of muscle functions. Besides the central nervous system, the therapeutic U7 RNA was expressed in the heart and liver which may additionally have contributed to the observed therapeutic efficacy. This approach provides an additional therapeutic option for Spinal Muscular Atrophy and could also be adapted to treat other diseases of the central nervous system with regulatory small RNA genes.
27456062	0	15	Somatic Therapy	T058	UMLS:C0037645
27456062	21	26	Mouse	T204	UMLS:C0025929
27456062	27	30	SMA	T038	UMLS:C0026847
27456062	31	36	Model	T038	UMLS:C0012644
27456062	44	57	U7 snRNA Gene	T017	UMLS:C2678677
27456062	69	73	SMN2	T017	UMLS:C1420258
27456062	74	82	Splicing	T038	UMLS:C0035687
27456062	83	106	Spinal Muscular Atrophy	T038	UMLS:C0026847
27456062	129	133	SMN1	T017	UMLS:C1420257
27456062	134	147	gene function	T038	UMLS:C0314627
27456062	153	167	duplicate gene	T017	UMLS:C0600497
27456062	168	172	SMN2	T017	UMLS:C1420258
27456062	204	215	SMN protein	T103	UMLS:C4283935
27456062	229	240	transcripts	T103	UMLS:C1519595
27456062	246	252	exon 7	T103	UMLS:C0015295
27456062	292	296	exon	T103	UMLS:C0015295
27456062	337	357	somatic gene therapy	T058	UMLS:C0037645
27456062	368	372	gene	T017	UMLS:C0017337
27456062	379	394	modified U7 RNA	T017	UMLS:C2678677
27456062	417	425	splicing	T038	UMLS:C0035687
27456062	456	474	therapeutic effect	T201	UMLS:C1527144
27456062	504	527	Spinal Muscular Atrophy	T038	UMLS:C0026847
27456062	528	539	mouse model	T038	UMLS:C2986594
27456062	558	565	U7 gene	T017	UMLS:C2678677
27456062	570	576	vector	T103	UMLS:C0017397
27456062	625	659	self-complementary (sc) adenovirus	T005	UMLS:C0001483
27456062	673	680	virus 9	T005	UMLS:C0001483
27456062	681	697	vector particles	T103	UMLS:C1520007
27456062	745	751	vector	T103	UMLS:C0017397
27456062	757	768	motoneurons	T017	UMLS:C0026609
27456062	780	803	Spinal Muscular Atrophy	T038	UMLS:C0026847
27456062	804	808	mice	T204	UMLS:C0025929
27456062	812	835	intracerebroventricular	T082	UMLS:C0595818
27456062	836	845	injection	T058	UMLS:C1533685
27456062	931	947	muscle functions	T038	UMLS:C0231484
27456062	961	983	central nervous system	T022	UMLS:C3714787
27456062	1001	1007	U7 RNA	T017	UMLS:C2678677
27456062	1012	1021	expressed	T038	UMLS:C0017262
27456062	1029	1034	heart	T017	UMLS:C0018787
27456062	1039	1044	liver	T017	UMLS:C0023884
27456062	1128	1136	approach	T082	UMLS:C0449445
27456062	1183	1206	Spinal Muscular Atrophy	T038	UMLS:C0026847
27456062	1236	1241	treat	T058	UMLS:C0087111
27456062	1248	1256	diseases	T038	UMLS:C0012634
27456062	1264	1286	central nervous system	T022	UMLS:C3714787
27456062	1292	1318	regulatory small RNA genes	T017	UMLS:C0017337